RYNE CARNEY

-Establishing a Neuroscience Center of Excellence within the FDA -Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (H.R. 5030/S.2706)

Signed Ad Hoc Group for Medical Research letter urging investments in medical research be included in any future legislative package focused on bolstering infrastructure. Further, the letter recommended that Congress pass the RISE Act (H.R. 869/S.289) Signed letter supporting the continued use of human fetal tissue in federal biomedical research

Signed a letter in support of the CONNECT for Health Act 2021 (S.1512) Signed a letter in support of the Comprehensive Care for Alzheimers Act (S. 1125/H.R. 2517) Signed a letter from the Medical Imaging and Technology Alliance (MITA) urging the Coverage and Analysis Group within CMS to open the pending reconsideration request for amyloid Positron Emission Tomography (PET) scans. Signed letter urging the House of Representatives and the Senate to create an out-of-pocket cap in Medicare Part D, reform the Part D exceptions and appeals process, bolster the low-income subsidy program, eliminate cost-sharing for Part D vaccines, and improve information and consumer education for Part D beneficiaries. Signed a letter as part of the Psychoactive Appropriate Use for Safety and Effectiveness (Project PAUSE) urging CMS to revise the measures of inappropriate use of antipsychotics in skilled nursing facilities and enhance the documentation to support CMSs ability to assess and investigate inappropriate prescribing practices Submitted letter to Congressional leadership urging an annual out-of-pocket cap in Part D; expansion of low-income subsidy eligibility; placing an inflationary cap in Part D; a requirement that Part D plans share a portion of sales of rebates with beneficiaries at the point of sale; strengthen the Part D appeals process; expand Medicare coverage for dental, vision, and hearing services; and not include the quality-adjusted life year metric in any drug pricing legislation. Sent letter to House of Representatives leadership urging them not to include International Reference Pricing and Quality-Adjust Life Year metrics in drug pricing legislation. Met virtually with the House of Representatives and Senate to discuss creating an annual out-of-pocket cap in Medicare Part D, creating a smoothing proposal, and warning against the use of quality-adjusted life-year metrics to determine drug value.

Signed a letter in support of the CONNECT for Health Act 2021 (S.1512) Signed a letter in support of the Comprehensive Care for Alzheimers Act (S. 1125/H.R. 2517) Signed a letter from the Medical Imaging and Technology Alliance (MITA) urging the Coverage and Analysis Group within CMS to open the pending reconsideration request for amyloid Positron Emission Tomography (PET) scans. Signed letter urging the House of Representatives and the Senate to create an out-of-pocket cap in Medicare Part D, reform the Part D exceptions and appeals process, bolster the low-income subsidy program, eliminate cost-sharing for Part D vaccines, and improve information and consumer education for Part D beneficiaries. Signed a letter as part of the Psychoactive Appropriate Use for Safety and Effectiveness (Project PAUSE) urging CMS to revise the measures of inappropriate use of antipsychotics in skilled nursing facilities and enhance the documentation to support CMSs ability to assess and investigate inappropriate prescribing practices Submitted letter to Congressional leadership urging an annual out-of-pocket cap in Part D; expansion of low-income subsidy eligibility; placing an inflationary cap in Part D; a requirement that Part D plans share a portion of sales of rebates with beneficiaries at the point of sale; strengthen the Part D appeals process; expand Medicare coverage for dental, vision, and hearing services; and not include the quality-adjusted life year metric in any drug pricing legislation. Sent letter to House of Representatives leadership urging them not to include International Reference Pricing and Quality-Adjust Life Year metrics in drug pricing legislation. Met virtually with the House of Representatives and Senate to discuss creating an annual out-of-pocket cap in Medicare Part D, creating a smoothing proposal, and warning against the use of quality-adjusted life-year metrics to determine drug value.

-Establishing a Neuroscience Center of Excellence within the FDA -Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (H.R. 5030/S.2706)

Signed Ad Hoc Group for Medical Research letter urging investments in medical research be included in any future legislative package focused on bolstering infrastructure. Further, the letter recommended that Congress pass the RISE Act (H.R. 869/S.289) Signed letter supporting the continued use of human fetal tissue in federal biomedical research

Signed a Protecting Access to Pain Relief (PAPR) Coalition letter urging HHS to explore and support new efforts and support new efforts to promote the work and recommendations of the HHS Pain Management Best Practices Inter-Agency Task Force. Signed letter in support of H.R. 8920, the Pioneering Antimicrobial Subscriptions to End Up surging Resistance (PASTEUR) Act

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the use of fetal tissue for biomedical research -Signed letter in support of H.R. 5668, the Making Objective Drug Evidence Revisions for New Labeling Act (MODERN Labeling Act).

-Signed letter in support of the use of fetal tissue for biomedical research -Signed letter in support of H.R. 5668, the Making Objective Drug Evidence Revisions for New Labeling Act (MODERN Labeling Act).

-Signed letter in support of the use of fetal tissue for biomedical research -Signed letter in support of H.R. 5668, the Making Objective Drug Evidence Revisions for New Labeling Act (MODERN Labeling Act).

-Signed letter in support of the use of fetal tissue for biomedical research -Signed letter in support of H.R. 5668, the Making Objective Drug Evidence Revisions for New Labeling Act (MODERN Labeling Act).

-Signed letter a letter from Justice in Aging on general principles for COVID-19 health emergency legislation The letter called to make racial equity an affirmative goal of all recovery programs, the collection of robust intersectional data on populations impacted by COVID-19; expansion of stimulus payments, increases in the SSI benefit; a suspension or raise to the asset limits for means tested programs including SSI, Medicaid, Medicare Savings Programs, Medicare Low Income subsidies, SNAP, LIHEAP, and other means tested program; extension of paid leave to all family caregivers; expansion of HCBS and Medicare Savings Programs; Increases to the FMAP; Expanded Medicare enrollment periods; Suspension of Medicare premiums for persons below 200 of the federal poverty line; require transparency about infections and staffing levels in nursing facilities and other licensed congregate settings; funding for the Access Act (S. 3517/H.R. 6487); ensure that language interpretation services are available for community-based organizations; ensure all caregivers and aging network services providers have adequate personal protective equipment; expand housing and protection supports, including section 202 supportive housing for seniors and energy assistance to HUD. -Signed letter requesting Congress require the CDC to update the COVID-19 surveillance systems to collect data on patients race, ethnicity, sex, age, primary language, sexual orientation, disability status, gender identity, and socioeconomic status in line with federal standards, and as a threshold, comport with the standards codified by Section 4302 of the Affordable Care Act. -Signed letter from the Consortium for Citizens with Disabilities (CCD) to write about concerns over a deadline for Society Security beneficiaries to file taxes or utilize a web tool claim economic impact payments for child dependents under the age of 17 or wait until 2021 to claim the payments. -Submitted a letter to CMS and the Office of Civil Rights asking they develop and release detailed guidance on how medical resources are being fairly allocated during the COVID-19 pandemic. -Signed a letter urging the FDA and NIH to consider factors that require individualization of treatment for pain, including genetic, sex, and age differences as they implement the SUPPORT Act. The letter asked NIH to implement section 7042 of the SUPPORT Act a priority to help clinicians and researchers individualize treatment plans and options.

Meeting with Senate Finance Committee staff to discuss recommendations for xx Signed letter asking requesting that all health education materials related to COVID-19 be accessible in at least 19 written languages and American Sign Language, support for interpretation services at COVID-19 testing sites, and to make comprehensive data available through the collection of regular reporting of language and disability characteristic of COVID-19 cases The Alliance for Aging Research publicly supported S.Res.655 - A resolution declaring racism a public health crisis. Signed a letter to House Telehealth Caucus in support of Protecting Access to Post-COVID-19 Telehealth Act of 2020 (HR 7663). Signed a letter requesting $10 million for the Administration on Community Living and $4 million for the Centers for Disease Control and Prevention to increase support for falls prevention. Had a meeting with Senate Finance staff to discuss the Committee's priorities to improve the treatment and care coordination for Alzheimer's disease patients after its hearing entitled "Alzheimers Awareness: Barriers to Diagnosis, Treatment, and Care Coordination" Signed letter requesting Congress address the need to expand access to COVID-19 and influenza testing and immunization by designating pharmacists as providers under Medicare Part B.

Signed a Friends of AHRQ letter in support of the AHRQ Funding Bill, H.R. 8067

-Signed letter to the Centers for Medicare and Medicaid over the concern in the increase in out-of-pocket expenses in Medicare Part D in 2020. -Signed letter to the Senate in support of S.2911, the Seniors Prescription Drug Relief Act of 2019.

-Signed letter to the Centers for Medicare and Medicaid over the concern in the increase in out-of-pocket expenses in Medicare Part D in 2020. -Signed letter to the Senate in support of S.2911, the Seniors Prescription Drug Relief Act of 2019.

-Signed letter to the Centers for Medicare and Medicaid over the concern in the increase in out-of-pocket expenses in Medicare Part D in 2020. -Signed letter to the Senate in support of S.2911, the Seniors Prescription Drug Relief Act of 2019.

-Signed letter to the Centers for Medicare and Medicaid over the concern in the increase in out-of-pocket expenses in Medicare Part D in 2020. -Signed letter to the Senate in support of S.2911, the Seniors Prescription Drug Relief Act of 2019.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

-Signed letter a letter from Justice in Aging on general principles for COVID-19 health emergency legislation The letter called to make racial equity an affirmative goal of all recovery programs, the collection of robust intersectional data on populations impacted by COVID-19; expansion of stimulus payments, increases in the SSI benefit; a suspension or raise to the asset limits for means tested programs including SSI, Medicaid, Medicare Savings Programs, Medicare Low Income subsidies, SNAP, LIHEAP, and other means tested program; extension of paid leave to all family caregivers; expansion of HCBS and Medicare Savings Programs; Increases to the FMAP; Expanded Medicare enrollment periods; Suspension of Medicare premiums for persons below 200 of the federal poverty line; require transparency about infections and staffing levels in nursing facilities and other licensed congregate settings; funding for the Access Act (S. 3517/H.R. 6487); ensure that language interpretation services are available for community-based organizations; ensure all caregivers and aging network services providers have adequate personal protective equipment; expand housing and protection supports, including section 202 supportive housing for seniors and energy assistance to HUD. -Signed letter requesting Congress require the CDC to update the COVID-19 surveillance systems to collect data on patients race, ethnicity, sex, age, primary language, sexual orientation, disability status, gender identity, and socioeconomic status in line with federal standards, and as a threshold, comport with the standards codified by Section 4302 of the Affordable Care Act. -Signed letter from the Consortium for Citizens with Disabilities (CCD) to write about concerns over a deadline for Society Security beneficiaries to file taxes or utilize a web tool claim economic impact payments for child dependents under the age of 17 or wait until 2021 to claim the payments. -Submitted a letter to CMS and the Office of Civil Rights asking they develop and release detailed guidance on how medical resources are being fairly allocated during the COVID-19 pandemic. -Signed a letter urging the FDA and NIH to consider factors that require individualization of treatment for pain, including genetic, sex, and age differences as they implement the SUPPORT Act. The letter asked NIH to implement section 7042 of the SUPPORT Act a priority to help clinicians and researchers individualize treatment plans and options.

Meeting with Senate Finance Committee staff to discuss recommendations for xx Signed letter asking requesting that all health education materials related to COVID-19 be accessible in at least 19 written languages and American Sign Language, support for interpretation services at COVID-19 testing sites, and to make comprehensive data available through the collection of regular reporting of language and disability characteristic of COVID-19 cases The Alliance for Aging Research publicly supported S.Res.655 - A resolution declaring racism a public health crisis. Signed a letter to House Telehealth Caucus in support of Protecting Access to Post-COVID-19 Telehealth Act of 2020 (HR 7663). Signed a letter requesting $10 million for the Administration on Community Living and $4 million for the Centers for Disease Control and Prevention to increase support for falls prevention. Had a meeting with Senate Finance staff to discuss the Committee's priorities to improve the treatment and care coordination for Alzheimer's disease patients after its hearing entitled "Alzheimers Awareness: Barriers to Diagnosis, Treatment, and Care Coordination" Signed letter requesting Congress address the need to expand access to COVID-19 and influenza testing and immunization by designating pharmacists as providers under Medicare Part B.

Submitted a letter regarding AHRQ's Systematic Review on Care Interventions for Person's with Dementia and their Caregivers. Wrote a letter in support of the S.692 Protect Medical Innovation Act of 2019 Signed letter using Congress to refund the Food and Drug Administration during the government shutdown Signed a letter requesting more budget authority for AHRQ Signed a letter in support of HR 1570, Removing Barriers to Colorectal Cancer Screening Attending Hill meeting on behalf of Protecting Access to Pain Relief (PAPR) Coalition H.R. 2063 The Opioid PACE Act to recommend medical practitioners receive training to be allowed to dispense opioid for pain management or pain relief

Submitted a letter regarding AHRQ's Systematic Review on Care Interventions for Person's with Dementia and their Caregivers. Wrote a letter in support of the S.692 Protect Medical Innovation Act of 2019 Signed letter using Congress to refund the Food and Drug Administration during the government shutdown Signed a letter requesting more budget authority for AHRQ Signed a letter in support of HR 1570, Removing Barriers to Colorectal Cancer Screening Attending Hill meeting on behalf of Protecting Access to Pain Relief (PAPR) Coalition H.R. 2063 The Opioid PACE Act to recommend medical practitioners receive training to be allowed to dispense opioid for pain management or pain relief

-Signed a letter supporting H.R. 2073, legislation to make the 7.5 percent threshold for medical expense deduction permanent.

The Alliance for Aging Research signed a letter of support for H.R. 2073, a bill to amend the Internal Revenue Code of 1986 to permanently extend the 7.5 percent adjusted gross income floor for the medical expense deduction. The Alliance for Aging Research signed a letter of support for S.110, the Medical Expense Savings Act which would make permanent the 7.5 percent threshold for the medical expense deduction. The Alliance for Aging Researched sent a letter to Capitol Hill in support of S. 692, the Protect Medical Innovation Act of 2019.

-Signed a letter supporting H.R. 2073, legislation to make the 7.5 percent threshold for medical expense deduction permanent.

-Signed letter requesting the delay of Protecting Access to Medicare Data Act (PAMA) data reporting period and supporting H.R. 3584, The Laboratory Access for Beneficiaries (LAB) Act. -Submitted meeting summary document to the Hill that found widespread support for an out-of-pocket cap for Medicare Part D, allowing for installment paying for Part D prescription drugs, and consideration of realigning incentives in the Part D program that may currently prefer higher-cost products. -Signed a Medicare Access for Patients Rx (MAPRx) letter that supported the out-of-pocket cap in Medicare Part D in the Prescription Drug Pricing Act of 2019. -Signed letter supporting Improving Seniors Timely Access to Care Act of 2019 (H.R. 3107) -Submitted letter thanking Sen. Menendez and Sen. Cassidy for working on introducing legislative language to allow for Medicare Part D beneficiaries to pay for their medications in installments. -Signed letter supporting an extension of a Centers for Medicare & Medicaid Services (CMS) program to provide equitable relief for select individuals enrolled in a Marketplace plan who delayed Medicare enrollment during their Initial Enrollment Period. -Signed letter to waive out-of-pocket costs for seniors on Medicare who have precancerous polyps removed during a colonoscopy. -Submitted letter regarding a CMS proposed rule Medicare and Medicaid Programs; Requirements for Long-Term Care Facilities: Regulatory Provisions To Promote Efficiency, and Transparency calling for changes to prescribing practices and the rating system for antipsychotics in long-term care facilities. -Ryne and Missy had meetings with Congressional staff to discuss allow the Medicare Part D program to allow for installment payments for prescription medication

-Signed letter requesting the delay of Protecting Access to Medicare Data Act (PAMA) data reporting period and supporting H.R. 3584, The Laboratory Access for Beneficiaries (LAB) Act. -Submitted meeting summary document to the Hill that found widespread support for an out-of-pocket cap for Medicare Part D, allowing for installment paying for Part D prescription drugs, and consideration of realigning incentives in the Part D program that may currently prefer higher-cost products. -Signed a Medicare Access for Patients Rx (MAPRx) letter that supported the out-of-pocket cap in Medicare Part D in the Prescription Drug Pricing Act of 2019. -Signed letter supporting Improving Seniors Timely Access to Care Act of 2019 (H.R. 3107) -Submitted letter thanking Sen. Menendez and Sen. Cassidy for working on introducing legislative language to allow for Medicare Part D beneficiaries to pay for their medications in installments. -Signed letter supporting an extension of a Centers for Medicare & Medicaid Services (CMS) program to provide equitable relief for select individuals enrolled in a Marketplace plan who delayed Medicare enrollment during their Initial Enrollment Period. -Signed letter to waive out-of-pocket costs for seniors on Medicare who have precancerous polyps removed during a colonoscopy. -Submitted letter regarding a CMS proposed rule Medicare and Medicaid Programs; Requirements for Long-Term Care Facilities: Regulatory Provisions To Promote Efficiency, and Transparency calling for changes to prescribing practices and the rating system for antipsychotics in long-term care facilities. -Ryne and Missy had meetings with Congressional staff to discuss allow the Medicare Part D program to allow for installment payments for prescription medication

-Signed a letter in support of H.R. 3584, The Laboratory Access for Beneficiaries (LAB) Act.

-Signed a letter in support of H.R. 3584, The Laboratory Access for Beneficiaries (LAB) Act.

The Alliance for Aging Research signed a letter in support of the House-proposed Dignity in Aging Act (HR 4334) to reauthorize the Older Americans Act.

The Alliance for Aging Research signed a letter in support of the House-proposed Dignity in Aging Act (HR 4334) to reauthorize the Older Americans Act.

The Alliance for Aging Research signed a letter of support for H.R. 2073, a bill to amend the Internal Revenue Code of 1986 to permanently extend the 7.5 percent adjusted gross income floor for the medical expense deduction. The Alliance for Aging Research signed a letter of support for S.110, the Medical Expense Savings Act which would make permanent the 7.5 percent threshold for the medical expense deduction. The Alliance for Aging Researched sent a letter to Capitol Hill in support of S. 692, the Protect Medical Innovation Act of 2019.

Missy Jenkins met with White House officials to discuss pain management and its policy on opioids. The Alliance for Aging Research signed a letter written by the Protecting Access to Pain Relief (PAPR) coalition responding to the Request for Public Comments on the Pain Management Best Practices Inter-Agency Task Force Draft Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations (HHS-OS-2018-0027-0001). The comments concerned the use of over-the-counter (OTC) pain relief as part of a patient's comprehensive pain management plan, as an alternative to opioids. The Alliance for Aging Research signed a letter of support for S.1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act written by S-FAR. The Alliance for Aging Researched signed a letter written by the National Patient Advocate Foundation to Capitol Hill in support of the Senate's Stopping the Outrageous Practice (STOP) of Surprise Bills Act of 2019.

-Signed letter expressing concern regarding two National Institutes of Health (NIH) guidances titled Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions Regarding Proposed Human Fetal Tissue Research. Our organization was concerned about proposed restrictions regarding federal research requiring the use of fetal tissue. -Signed letter opposing Section 207 of S. 1895 the Lower Health Care Costs Act. --Signed letter supporting the appointment of Dr. Norman E. Sharpless as the Commissioner of the Food and Drug Administration

The Alliance for Aging Research signed a letter of support for H.R. 2073, a bill to amend the Internal Revenue Code of 1986 to permanently extend the 7.5 percent adjusted gross income floor for the medical expense deduction. The Alliance for Aging Research signed a letter of support for S.110, the Medical Expense Savings Act which would make permanent the 7.5 percent threshold for the medical expense deduction. The Alliance for Aging Researched sent a letter to Capitol Hill in support of S. 692, the Protect Medical Innovation Act of 2019.

Submitted a letter regarding AHRQ's Systematic Review on Care Interventions for Person's with Dementia and their Caregivers. Wrote a letter in support of the S.692 Protect Medical Innovation Act of 2019 Signed letter using Congress to refund the Food and Drug Administration during the government shutdown Signed a letter requesting more budget authority for AHRQ Signed a letter in support of HR 1570, Removing Barriers to Colorectal Cancer Screening Attending Hill meeting on behalf of Protecting Access to Pain Relief (PAPR) Coalition H.R. 2063 The Opioid PACE Act to recommend medical practitioners receive training to be allowed to dispense opioid for pain management or pain relief

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

Antimicrobial resistance funding and research; heart disease; appropriations for NIH/FDA/AHRQ/CDC; Short term limited duration plans (STLDP) in Medicare; FDA guidance on Alzheimer's Disease Research; adult vaccinations in Medicare; opposition to the Balanced Budget Act; opposition to S.204/H.R.5247 Right to Try legislation

Support increased funding for federal antimicrobial resistance initiatives (S.2469) STAAR and the reauthorization of the Pandemic and All-Hazards Preparedness Act (not yet introduced) Support for CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Support Medicare vulnerable populations as part of Medicare Extenders bill (H.R.Res 128) included in the CR Oppose Right to Try bill (H.R.5247 & S.204) Support Agency for Healthcare Research & Quality increased appropriations FY19

Antimicrobial resistance funding and research; heart disease; appropriations for NIH/FDA/AHRQ/CDC; Short term limited duration plans (STLDP) in Medicare; FDA guidance on Alzheimer's Disease Research; adult vaccinations in Medicare; opposition to the Balanced Budget Act; opposition to S.204/H.R.5247 Right to Try legislation

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

Co-signed a letter to HHS in opposition to transferring existing federal dollars away from HHS/ACL programs for seniors to the border security issues. Co-signed a letter to Senate in support of S.3519 - the Making Objective Drug Evidence Revisions for New Labeling Act. Co-signed a letter to Congress in support of repeal of the device tax. Co-signed letter to the Chairs and Ranking Members of the House and Senate Appropriations Committees thank them for their leadership to increase medical and public health research in the Fiscal Year 2019 Labor, Health and Human Services, Education/Defense Appropriations conference report (H.R. 6157)

Antimicrobial resistance funding and research; heart disease; appropriations for NIH/FDA/AHRQ/CDC; Short term limited duration plans (STLDP) in Medicare; FDA guidance on Alzheimer's Disease Research; adult vaccinations in Medicare; opposition to the Balanced Budget Act; opposition to S.204/H.R.5247 Right to Try legislation

Support increased funding for federal antimicrobial resistance initiatives (S.2469) STAAR and the reauthorization of the Pandemic and All-Hazards Preparedness Act (not yet introduced) Support for CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Support Medicare vulnerable populations as part of Medicare Extenders bill (H.R.Res 128) included in the CR Oppose Right to Try bill (H.R.5247 & S.204) Support Agency for Healthcare Research & Quality increased appropriations FY19

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

Antimicrobial resistance funding and research; heart disease; appropriations for NIH/FDA/AHRQ/CDC; Short term limited duration plans (STLDP) in Medicare; FDA guidance on Alzheimer's Disease Research; adult vaccinations in Medicare; opposition to the Balanced Budget Act; opposition to S.204/H.R.5247 Right to Try legislation

Support increased funding for federal antimicrobial resistance initiatives (S.2469) STAAR and the reauthorization of the Pandemic and All-Hazards Preparedness Act (not yet introduced) Support for CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Support Medicare vulnerable populations as part of Medicare Extenders bill (H.R.Res 128) included in the CR Oppose Right to Try bill (H.R.5247 & S.204) Support Agency for Healthcare Research & Quality increased appropriations FY19

-S. 2749 Opioid Addiction Plan Act -Docket ID: FDA-2018-N-2689 Facilitating Competition and Innovation in the Biological Products Marketplace -Commented HHS on Drug Pricing Blueprint (HHS-OS-2018-0010)

Co-signed a letter to HHS in opposition to transferring existing federal dollars away from HHS/ACL programs for seniors to the border security issues. Co-signed a letter to Senate in support of S.3519 - the Making Objective Drug Evidence Revisions for New Labeling Act. Co-signed a letter to Congress in support of repeal of the device tax. Co-signed letter to the Chairs and Ranking Members of the House and Senate Appropriations Committees thank them for their leadership to increase medical and public health research in the Fiscal Year 2019 Labor, Health and Human Services, Education/Defense Appropriations conference report (H.R. 6157)

CR (FY 2018 Appropriations for the National Institutes of Health) CR (FY 2018 Appropriations for the Food and Drug Administration) Increased funding for federal antimicrobial resistance initiatives Letter support of nomination of HHS Sec. Alex Azar Letter of Recommendations for NIH National Research Summit AFib non medical switching to CMS letter HR1 Tax Cuts and Jobs Act, medical expenses tax deduction letter IPAB repeal support letter S.1909 support letter Bene enrollment simplification (2 letters) letter protect Medicare State Health Insurance Assistance Program (SHIP) for FY18 letter biosimilars in the coverage gap rebate

Adult Immunization Stroke Prevention Low Income Subsidy in Medicaid OTC pain medication and opioids Part D coverage gap Afib non medical switching NIH Nat'l Research Summit recommendations HR1 tax bill medical exp deduction

CR (FY 2018 Appropriations for the National Institutes of Health) CR (FY 2018 Appropriations for the Food and Drug Administration) Increased funding for federal antimicrobial resistance initiatives Letter support of nomination of HHS Sec. Alex Azar Letter of Recommendations for NIH National Research Summit AFib non medical switching to CMS letter HR1 Tax Cuts and Jobs Act, medical expenses tax deduction letter IPAB repeal support letter S.1909 support letter Bene enrollment simplification (2 letters) letter protect Medicare State Health Insurance Assistance Program (SHIP) for FY18 letter biosimilars in the coverage gap rebate

H.R. 6 21st Century Cures Act Senate Initiative on Multiple Chronic Conditions Adult Immunization Healthcare Associated Infections Stroke Prevention Senate Initiative on Medical Innovation NIH Research Prioritization Geroscience Coordinating Committee Antibiotic Stewardship FDA combination products review

H.R. 6 21st Century Cures Act Adult Immunization Healthcare Associated Infections Stroke Prevention Heart Valve Disease Awareness Senate Initiative on Medical Innovation Geroscience Coordinating Committee Antibiotic Stewardship Regenerative Medicine Value Frameworks and Older Adults

H.R. 6 21st Century Cures Act Senate Initiative on Multiple Chronic Conditions Adult Immunization Healthcare Associated Infections Stroke Prevention Senate Initiative on Medical Innovation NIH Research Prioritization Geroscience Coordinating Committee Antibiotic Stewardship Regenerative Medicine FDA combination products review

H.R. 6 21st Century Cures Act Adult Immunization Healthcare Associated Infections Stroke Prevention Heart Valve Disease Awareness Senate Initiative on Medical Innovation Geroscience Coordinating Committee Antibiotic Stewardship Regenerative Medicine

H.R. 6 21st Century Cures Act S. 1920 Older Americans Act Reauthorization H.R. 160 Medical Device Tax Repeal Senate Initiative on Medical Innovation Senate Initiative on Multiple Chronic Conditions The Antibiotic Development to Advance Patient Treatment (ADAPT) Act Assisting Caregivers Today (ACT) Caucus Government Restrictions on Federal Employee Scientific Conference Participation and Travel

H.R. 6 21st Century Cures Act H.R. 160 Medical Device Tax Repeal Senate Initiative on Multiple Chronic Conditions Adult Immunization Healthcare Associated Infections Stroke Prevention Senate Initiative on Medical Innovation NIH Research Prioritization Geroscience Coordinating Committee Antibiotic Stewardship and Infection Reporting in Long-Term Care Facilities

H.R. 6 21st Century Cures Act Medical Device Tax Repeal Senate Initiative on Multiple Chronic Conditions Adult Immunization Healthcare Associated Infections Stroke Prevention Senate Initiative on Medical Innovation NIH Research Prioritization Geroscience Coordinating Committee Antibiotic Stewardship

H.R. 6 21st Century Cures Act H.R. 160 Medical Device Tax Repeal Senate Initiative on Multiple Chronic Conditions Adult Immunization Healthcare Associated Infections Stroke Prevention Senate Initiative on Medical Innovation NIH Research Prioritization Geroscience Coordinating Committee Antibiotic Stewardship and Infection Reporting in Long-Term Care Facilities

H.R. 6 21st Century Cures Act S. 1920 Older Americans Act Reauthorization H.R. 160 Medical Device Tax Repeal Senate Initiative on Medical Innovation Senate Initiative on Multiple Chronic Conditions The Antibiotic Development to Advance Patient Treatment (ADAPT) Act Assisting Caregivers Today (ACT) Caucus Government Restrictions on Federal Employee Scientific Conference Participation and Travel

H.R. 6 21st Century Cures Act S. 1920 Older Americans Act Reauthorization H.R. 160 Medical Device Tax Repeal Senate Initiative on Medical Innovation Senate Initiative on Multiple Chronic Conditions The Antibiotic Development to Advance Patient Treatment (ADAPT) Act Assisting Caregivers Today (ACT) Caucus Government Restrictions on Federal Employee Scientific Conference Participation and Travel